๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 12 Aug 2026 ยท ClinicalTrials.gov

Clinical Trials in Bengaluru

โ† All India trials

Every active and recruiting clinical study with an investigative site in India โ€” searchable by condition, sponsor, phase and location. Refreshed daily from the ClinicalTrials.gov registry.

1
Recruiting now
6
Active studies
Starting soon
Eelderly With Sleep Disturbances
University of Pittsburgh ยท started 2027-02
๐Ÿ“ Bengaluru
NCT06652789 on ClinicalTrials.gov โ†—
Recruiting Phase 3
Colitis, Ulcerative
Janssen Research & Development, LLC ยท started 2025-10-01
๐Ÿ“ Bangalore ยท Bengaluru ยท Bhubaneswar ยท Ernฤkulam ยท Gurugram ยท Hyderabad
NCT07196748 on ClinicalTrials.gov โ†—
Active Phase 4
RSV Immunization
Sanofi ยท started 2025-07-31
๐Ÿ“ Bengaluru ยท Jaipur ยท Kolkata ยท Nagpur ยท New Delhi ยท Pune
NCT07109297 on ClinicalTrials.gov โ†—
Active Phase 3
IgA Nephropathy, Immunoglobulin A Nephropathy
Novartis Pharmaceuticals ยท started 2023-07-06
๐Ÿ“ Hyderabad ยท Chandigarh ยท Faridabad ยท Bengaluru ยท Trivandrum ยท Jaipur
NCT05852938 on ClinicalTrials.gov โ†—
Active Phase 1
Advanced Solid Tumor, Lymphoma
Glenmark Specialty S.A. ยท started 2022-06-28
๐Ÿ“ Vijayawada ยท Visakhapatnam ยท Gurgaon ยท Bangalore ยท Bengaluru ยท Kannur
NCT05878691 on ClinicalTrials.gov โ†—
Active Phase 3
Breast Cancer
Tolmar Inc. ยท started 2021-07-01
๐Ÿ“ Vijayawada ยท Visakhapatnam ยท Ahmedabad ยท Surat ยท Bengaluru ยท Mysore
NCT04906395 on ClinicalTrials.gov โ†—
No trials match your search.

Browse by location

New Delhi ยท 21 Mumbai ยท 18 Hyderabad ยท 16 Bangalore ยท 11 Pune ยท 10 Chandigarh ยท 10 Ahmedabad ยท 10 Kolkata ยท 7 Jaipur ยท 7 Surat ยท 7 Bengaluru ยท 6 Lucknow ยท 6

Browse by condition

Breast Cancer ยท 3 Lupus Nephritis ยท 2 Cervical Cancer ยท 2 Hepatic Encephalopathy ยท 2 Periodontitis ยท 2
Cite this page

Priya Life Science (2026). Clinical Trials in India Tracker. Available at: https://priyalifescience.com/clinical-trials-india/city/bengaluru (Accessed: 12 August 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine โ€” studies listing at least one Indian site, refreshed daily. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician.